Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions

Area of Science:

• Oncology
• Metabolism
• Pathophysiology

Background:

• Cancer cachexia is a complex metabolic syndrome characterized by significant weight loss and skeletal muscle depletion during cancer progression.
• This condition severely impacts patient quality of life, immune function, and survival.
• Current treatments lack the ability to fully reverse or ameliorate cancer cachexia.

Purpose of the Study:

• To provide a comprehensive review of cancer cachexia.
• To discuss underlying pathophysiological mechanisms, preclinical models, clinical assessment methods, biomarkers, and therapeutic strategies.
• To contribute to the development of effective counteractive strategies against cancer cachexia.

Main Methods:

• Literature review of existing research on cancer cachexia.
• Analysis of pathophysiological mechanisms and preclinical models.
• Evaluation of clinical assessment techniques and biomarkers.
• Exploration of potential therapeutic interventions.

Main Results:

• Detailed overview of the multifactorial nature of cancer cachexia.
• Identification of key pathophysiological pathways involved in muscle wasting and metabolic disruption.
• Summary of current preclinical findings and their translational potential.
• Discussion of challenges and opportunities in clinical assessment and biomarker discovery.

Conclusions:

• Cancer cachexia remains a significant challenge in oncology with profound effects on patients.
• Understanding the complex mechanisms is crucial for developing targeted therapies.
• Further research into preclinical models and biomarkers is essential for advancing therapeutic strategies and improving patient survival and quality of life.